Gene: PHF19
Official Full Name: PHD finger protein 19provided by HGNC
Gene Summary: Enables methylated histone binding activity. Involved in negative regulation of gene expression, epigenetic. Located in ESC/E(Z) complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03839 | PHF19 Knockout cell line (HeLa) | Human | PHF19 | 1:3~1:6 | Negative | Online Inquiry |
KO03840 | PHF19 Knockout cell line (HCT 116) | Human | PHF19 | 1:2~1:4 | Negative | Online Inquiry |
KO03841 | PHF19 Knockout cell line (HEK293) | Human | PHF19 | 1:3~1:6 | Negative | Online Inquiry |
KO03842 | PHF19 Knockout cell line (A549) | Human | PHF19 | 1:3~1:4 | Negative | Online Inquiry |
PHF19 Gene Knockout Cell Lines are sophisticated tools designed for researchers focused on understanding the biological role of the PHF19 gene, which is implicated in various cellular processes, including epigenetic regulation and transcriptional control. By employing CRISPR-Cas9 gene-editing technology, these cell lines feature precise deletions of the PHF19 gene, allowing for in-depth studies of gene function, cellular pathways, and the implications of PHF19 dysregulation in diseases, particularly cancer and developmental disorders.
The primary function of PHF19 Gene Knockout Cell Lines is to facilitate functional genomics studies. Without the PHF19 gene's influence, researchers can observe changes in cellular behavior, gene expression, and protein interactions. This knockout model serves as a critical reference point for investigating the consequences of PHF19 loss, enabling insights into mechanisms of disease pathology, therapeutic targets, and potential biomarkers.
The scientific importance of this product lies in its applications within both research and clinical settings, particularly in the field of cancer biology and developmental genetics. By providing a controlled environment to scrutinize gene function, these cell lines pave the way for identifying novel therapeutics and elucidating the molecular underpinnings of disease states.
Compared to traditional methods of gene knockdown, our PHF19 Gene Knockout Cell Lines offer unparalleled specificity and efficiency, ensuring that researchers receive consistent and reproducible results. The CRISPR-Cas9 technology used eliminates off-target effects commonly associated with alternative gene silencing methods, enhancing the reliability of experimental outcomes.
For researchers and clinicians alike, the value of PHF19 Gene Knockout Cell Lines is pronounced. This product not only enables comprehensive exploration of gene function but also aids in the acceleration of translational research efforts toward developing innovative therapies. Coupled with our expertise in gene editing and a commitment to quality, our company stands at the forefront of providing cutting-edge biological products that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.